Diversify Advisory Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,692
Closed -$311K 427
2025
Q4
$311K Sell
3,692
-17,537
-83% -$1.44M 0.01% 747
2025
Q3
$1.76M Sell
21,229
-6,719
-24% -$525K 0.06% 230
2025
Q2
$2.15M Buy
27,948
+4,297
+18% +$320K 0.08% 178
2025
Q1
$1.8M Buy
23,651
+4,650
+24% +$333K 0.11% 130
2024
Q4
$1.4M Sell
19,001
-2,698
-12% -$189K 0.08% 180
2024
Q3
$1.5M Sell
21,699
-1,877
-8% -$136K 0.08% 196
2024
Q2
$2.2M Sell
23,576
-6,234
-21% -$552K 0.12% 149
2024
Q1
$2.81M Buy
+29,810
New +$2.5M 0.17% 130

Other funds holding EW

Diversify Advisory Services's EW Position: Q1 2026 in Review

Diversify Advisory Services sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 3,692 shares — an estimated $311K sold.

Diversify Advisory Services first reported a position in EW in Q1 2024 and held it in 8 quarters. The position peaked at $2.81M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Diversify Advisory Services reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Diversify Advisory Services sold 3,692 Edwards Lifesciences shares in Q1 2026, an estimated $311K.
  • Diversify Advisory Services first reported a position in Edwards Lifesciences in Q1 2024 and held it in 8 quarters.
  • Diversify Advisory Services's Edwards Lifesciences position peaked at $2.81M in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Diversify Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.